Consequences of the variability of the CovRS and RopB regulators among Streptococcus pyogenes causing human infections by Friães, Ana et al.
1Scientific RepoRts | 5:12057 | DOi: 10.1038/srep12057
www.nature.com/scientificreports
Consequences of the variability of 
the CovRS and RopB regulators 
among Streptococcus pyogenes 
causing human infections
Ana Friães*, Catarina Pato*, José Melo-Cristino & Mario Ramirez
To evaluate the importance of covRS and ropB mutations in invasive disease caused by Group A 
Streptococci (GAS), we determined the sequence of the covRS and ropB genes of 191 isolates from 
invasive infections and pharyngitis, comprising a diverse set of emm types and multilocus sequence 
types. The production of SpeB and the activity of NAD glycohydrolase (NADase) and streptolysin S 
(SLS) were evaluated. The results support the acquisition of null covS alleles (predicted to eliminate 
protein function), resulting in downregulation of SpeB and upregulation of NADase and SLS, as a 
mechanism possibly contributing to higher invasiveness. Among the isolates tested, this mechanism 
was found to be uncommon (10% of invasive isolates) and was not more prevalent among clones 
with enhanced invasiveness (including M1T1) but occurred in diverse genetic backgrounds. In lineages 
such as emm64, these changes did not result in upregulation of NADase and SLS, highlighting the 
diversity of regulatory pathways in GAS. Despite abrogating SpeB production, null alleles in ropB 
were not associated with invasive infection. The covRS and ropB genes are under stabilising selection 
and no expansion of isolates carrying null alleles has been observed, suggesting that the presence of 
these regulators is important for overall fitness.
Streptococcus pyogenes (Group A Streptococci, GAS) is a human pathogen that can asymptomatically 
colonize the oropharynx, but is also responsible for a variety of human diseases, ranging from uncom-
plicated superficial infections of the respiratory tract and skin, such as pharyngitis and impetigo, to 
severe invasive infections associated with high morbidity and mortality, like necrotizing fasciitis and 
streptococcal toxic shock syndrome (STSS)1.
The recognition of the ability of strains belonging to the highly invasive M1T1 clone to acquire muta-
tions in the covRS genes during skin and soft tissue infection in mice suggested that GAS could increase 
its capacity to invade deeper tissues by altering its regulatory networks in order to produce a switch to 
an invasive transcriptome profile2,3. The adjacent and cotranscribed genes covR and covS encode the 
two-component regulatory system CovRS (also known as CsrRS). The DNA-binding response regulator 
CovR acts mostly as a repressor of transcription upon phosphorylation by the sensor kinase/phosphatase 
CovS, which responds to stress factors, such as elevated temperatures, high saline concentrations, and 
decreased pH4. CovRS is estimated to directly or indirectly influence the expression of 10–15% of the 
GAS genome. Although it is also involved in the regulation of metabolic genes, it is mostly known for 
controlling the expression of a large number of genes encoding factors that promote GAS virulence and 
evasion of the host immune system5,6. Most studies indicate that mutations impairing CovRS function 
result in the upregulation of genes encoding the hyaluronic acid capsule, streptolysins S and O, streptoki-
nase, DNases, the interleukin-protease SpyCEP, and NAD-glycohydrolase (NADase), among others, and 
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in the downregulation of proteins like the extracellular cysteine protease SpeB and the protein-G-related 
α 2-macroglobulin-binding protein GRAB7,8. However, contrasting results have been reported regarding 
the effect of covRS mutations in some of those virulence factors, which may be partly explained by the 
interaction of CovRS with other transcriptional regulators, resulting in complex regulation patterns that 
can vary between different strains8,9.
Mutations in CovRS and in the stand-alone transcriptional regulator RopB have been identified 
in isolates recovered from human infections7,10–12. RopB (also known as Rgg) is encoded by the 
ropB (rgg) gene, which is located 940 bp away from speB, in the opposite DNA strand, and directly 
binds the promoter of the latter gene to activate its transcription13. In some strains, this regulator 
has been reported to affect the transcription of other virulence factors, including DNases, the 
hyaluronic acid capsule, NADase, streptokinase, streptolysins, and phage-encoded superantigens, 
among others10,11.
The downregulation of SpeB, which is usually observed as a consequence of CovRS and RopB muta-
tions, is considered to be a determining step in the transition to an invasive phenotype, since this potent 
protease degrades several extracellular GAS virulence factors that play an important role in the invasive 
process, including the M protein, the F1 protein, C5a peptidase, streptokinase, and SmeZ14. In agree-
ment, SpeB production has been inversely correlated with disease severity, in both human infections 
and murine models15,16. SpeB is initially synthesised and secreted as an inactive 42-kDa zymogen, which 
is then autocatalytically processed through a series of intermediates to form the 28-kDa mature active 
protease. Each stage from transcription to mature SpeB involves tight regulatory controls, including 
post-transcriptional and post-translational mechanisms14.
Some studies suggest that covRS and ropB mutations occur more frequently among isolates from 
invasive infections, while others found them in a similar proportion among non-invasive isolates7,11,12. 
Contrasting observations have also been reported regarding the impact of alterations in these regulators 
on virulence using animal models, as well as on the expression of virulence factors like SpeB and the 
streptolysins2,3,5,7,8,11,17–20. Given these discrepancies and the fact that most of the studies have focused on 
particular emm types, especially emm1 and emm3, the importance of the acquisition of these mutations 
for the overall invasiveness and virulence of GAS strains is still not completely understood.
In order to address these questions, we sequenced the covRS and ropB genes in a collection of 191 
GAS isolates presenting a high diversity of emm types and multilocus sequence types (STs), including 
the most prevalent clones causing pharyngitis and invasive infections in Portugal and in a majority of 
other countries from temperate climate regions21–23. The genetic diversity of the genes was evaluated, and 
the respective alleles were correlated with the activity of SpeB and of two other virulence factors whose 
expression has been suggested to be under the influence of CovRS and RopB, at least in some strains, 
namely the NADase and the streptolysin S (SLS)7,11,18,24.
Results
Genetic variation of the covR, covS and ropB genes. In the present work, the sequence of the 
covR, covS, and ropB genes was determined for a collection of 191 isolates (Supplementary Table S1) 
comprising one third of the isolates of each emm type present in a larger collection of strains recovered 
from pharyngitis and invasive infections in Portugal, which has been characterized elsewhere21. In addi-
tion, all isolates of emm types 1 and 64 were included in this study, since these two emm types were 
shown to be significantly associated with invasive disease.
The three genes presented a high allelic diversity in the studied GAS collection, with Simpson’s 
index of diversity (SID) values close to the ones obtained for emm type and ST (Table  2). The allelic 
diversity of the covR genes was lower than that of covS (P = 0.0140) and of the ST (P = 0.0137). Overall, 
isolates sharing the same emm type or ST frequently shared the same covR, covS, and ropB alleles 
(Supplementary Table S2). This association was stronger for covR, in line with the lower allelic diversity 



















diversity Ka/Ks P value
covR 54 (19) 32 (5) 1 2 0.0058 0.19 0.0032
covS 121 (43) 83 (26) 28a 11 0.0043 0.14 0.0029
ropB 78 (37c) 56 (21c) 7b 2 0.0055 0.23 0.0015
Table 1.  Type of amino acid alteration, nucleotide diversity, and Ka/Ks values associated with the 
covR, covS, and ropB alleles described in this study and those previously reported in GenBank. aThree 
of the covS indels are in frame. bTwo of the ropB indels are in frame, but one of these deletes a considerable 
portion of the protein (119 residues). cExcluding the isolate with a complete ropB deletion.
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essentially clonal properties, although some level of intra-clonal diversity was observed, particularly for 
covS and ropB.
Together with the alleles previously deposited in GenBank, we identified a total of 54 alleles for covR, 
121 for covS, and 78 for ropB (Table 1). One of the isolates in our study is devoid of the ropB gene due to a 
previously characterized deletion that also involves the speB gene25. Alterations relative to the nucleotide 
sequence of the three genes in strain SF370 are depicted in Fig. 1. For each of the genes, more than half 
of the alleles result in alterations in the amino acid sequence, with ropB presenting the highest proportion 
of distinct amino acid sequences relative to the total number of alleles. However, all the Ka/Ks ratios 
were significantly lower than 1 (Table 1), indicating that all three genes are under stabilising selection. 
Ka/Ks is the ratio of the number of nonsynonymous substitutions per nonsynonymous site to the num-
ber of synonymous substitutions per synonymous site. This measure is often used to evaluate deviations 
from neutral evolution. A value of Ka/Ks < < 1 indicates that the protein is under stabilising selection, 
i.e. selection favours alleles that do not change the amino acid sequence. In contrast, a value of Ka/Ks 
> > 1 is strong evidence for positive selection, indicating that selection drove changes to the protein26. 
Nucleotide diversity was also similar for the three genes, with differences in the total number of alleles 
basically reflecting the different sizes of the genes (687 bp for covR, 1503 bp for covS, and 843 bp for 
ropB). Null alleles were defined as those presenting changes predicted to result in a complete absence of 
protein function – including nonsense mutations, indels that result in frameshifts, large in-frame indels 
( ≥ 357 bp), and complete gene deletions. In spite of similar diversity, the covS gene presented more null 
alleles than covR (P = 0.0004).
Mutations in covR, covS, and ropB, and association with emm type and invasiveness. For 
covR and ropB, the reference alleles (those present in SF370) were the most common among the 191 
GAS isolates analysed in this study [n = 67 (35%), and n = 69 (36%), respectively]. The SF370 covS allele 
was present in only five isolates, but 68 isolates (36%) presented only synonymous nucleotide changes 
(15 alleles). Since our collection was enriched in emm1 isolates, the most common covS allele (covS-02, 
28%) included a missense mutation characteristic of the M1T1 clone, namely I332 V. Other missense 
mutations were also commonly identified in isolates of specific emm types, in both covS and ropB genes.
In addition to the coding sequence of the genes, the region upstream of covR, which includes the 
covRS promoter, was also analysed for all isolates, but no nucleotide changes were found in the identi-
fied −35 and −10 regions, in the transcription start site, nor in the consensus sequences that have been 
identified as binding targets for CovR auto-repression27.
The overall distribution of emm types differed significantly between the isolates carrying missense 
or null alleles of covR, covS, or ropB and those with no amino acid alterations (P < 0.0001). Null alleles 
were not associated with any particular emm type, occurring in isolates of seven different emm types for 
covS (SID = 0.909 [CI95% 0.822–0.996]) and of four different emm types in the case of ropB (SID = 0.867 
[CI95% 0.738–0.995]). Missense mutations in covS and ropB were significantly more prevalent in isolates 
of certain emm types due to the presence of clonal alleles in specific lineages, i.e. alleles carrying amino 
acid changes that occur in several isolates of that emm type (Supplementary Table S1).
According to the SID values, the allele diversity of the three genes was similar for the subsets of iso-
lates associated with pharyngitis and with invasive infections (Table 2). The overall distribution of covS 
and ropB alleles was significantly different between the two subsets (P < 0.0001), but no specific covR, 
covS, or ropB allele presented a significant association with either infection type after correcting for the 
false discovery rate (FDR), except for ropB-23, which was significantly associated with invasive infections 
(P = 0.0109). This association is explained by the fact that ropB-23 was present in all emm64 isolates and 
not found in any other emm type (Supplementary Table S1), and emm64 was significantly associated with 
invasive infections in Portugal21. This allele presents only two synonymous nucleotide changes, which are 
not likely to be the cause of the high invasiveness of this lineage.
Gene







covR 19 0.831 [0.793–0.870] 17 0.816 [0.752–0.880] 13 0.839 [0.794–0.885]
covS 43 0.893 [0.861–0.925] 31 0.870 [0.811–0.930] 25 0.905 [0.873–0.938]
ropB 38 0.850 [0.805–0.896] 23 0.806 [0.729–0.883] 29 0.879 [0.828–0.929]
emm type 26 0.877 [0.844–0.910] 20 0.833 [0.769–0.898] 20 0.900 [0.868–0.932]
ST 41 0.894 [0.861–0.927] 27 0.860 [0.798–0.922] 32 0.910 [0.876–0.945]
Table 2.  Simpson’s index of diversity (SID) and corresponding 95% confidence intervals (CI95%) of 
the alleles of covR, covS, and ropB, the emm types, and the STs identified among the 191 GAS isolates 
analysed in this study.
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Figure 1. Nucleotide alterations identified in the covR (A), covS (B), and ropB (C) alleles reported 
in this study and previously deposited in GenBank, relative to the alleles present in strain SF370 
(AE004092). Each gene is indicated by a grey arrow and a nucleotide numbering scale is represented below 
each one. Each sequence variation is indicated in the respective nucleotide position by a letter corresponding 
to the variant nucleotide, or the sequence or number of base-pairs inserted (ins), deleted (del), or duplicated 
(dup). Synonymous nucleotide changes are represented in black; missense mutations and short in-frame 
indels ( ≤ 6 bp) are represented in blue; changes predicted to result in null alleles, including nonsense 
mutations, indels that generate frameshifts, and long in-frame indels ( ≥ 357 bp) are represented in red.
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The presence of an altered amino acid sequence in general was not associated with infection type for 
any of the genes. However, null covS alleles were significantly overrepresented among the invasive isolates 
(P = 0.0247) (Table 3), even though they were only present in nine of these isolates (10%).
SpeB production. In this study, the presence or absence of extracellular proteolytic activity was tested 
for all isolates using a spectrophotometric assay based on the degradation of azocasein by culture super-
natants, as well as by a plate assay in which the strains were cultured in solid medium containing casein. 
To confirm that the proteolytic activity detected by these two methods was essentially due to SpeB, which 
has been described as the major extracellular protease of GAS28, Western blot analysis using monoclo-
nal anti-SpeB antibodies was performed in a subset of six isolates of emm types 1, 64 and 89. For each 
emm type, one protease-positive and one protease-negative isolate were randomly chosen. The presence 
of a 28-kDa band similar to the one detected for SF370 was considered as a positive result (Fig. 2). The 
Western blot results were concordant with those of the two proteolytic activity assays for this subset of 
isolates. The emm1 strains SF370 and MGAS5005 were used as controls in all assays. As expected, strain 
SF370, which encodes a functional CovRS, presented proteolytic activity in both assays and was positive 
for mature SpeB production by Western blotting. In contrast, almost undetectable amounts of mature 
SpeB and no proteolytic activity were observed for MGAS5005, which harbours a frameshift mutation 
in covS (Fig. 2 and Fig. 3). Taken together, these results confirm that SpeB is the major protease of GAS, 
allowing us to use the total proteolytic activity as a proxy for SpeB activity. Western blot was also per-
formed for all isolates in which the azocasein and casein-plate results were discordant (n = 31). In these 
cases, the Western blot result was considered as final.
Of a total of 191 isolates, 153 (80%) presented SpeB activity, while for the remaining 38 (20%) no 
SpeB activity could be detected (Fig. 3 and Supplementary Table S1). All isolates with null alleles, either 
in covS or in ropB, were associated with an absence of SpeB activity (P < 0.0001 for both). In contrast, 
the prevalence of missense alleles among the SpeB-negative and SpeB-positive isolates was similar, except 
for non-clonal missense alleles in ropB (i.e. missense alleles that were not identified in other isolates of 






covR Null 0 0
Missense 2 2
covS Null 9 2
Missense 51 61
ropB Null 3 3
Missense 13 26
covRS/ropB Null 12 5
Missense 56 72
Table 3.  Number of isolates from invasive infections and pharyngitis presenting null and missense 
alleles in the covR, covS, and ropB genes.
Figure 2. Representative Western blot result for detection of mature SpeB (28 kDa) expression by GAS 
isolates. The blot shown was cropped to the region of interest.
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Figure 3. SpeB production and NADase and SLS activity determined for the 191 isolates analysed in 
this study, according to emm type. The emm types represented by < 5 isolates are grouped into “Others” 
and include emm 9, 11, 18, 29, 43, 53, 58, 74, 77, 78, 87, 94, 102 and 113. The results of reference strains 
SF370 and MGAS5005 are also presented.
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SpeB production (P = 0.0008). Only two SpeB-negative isolates presented alleles encoding the reference 
amino acid sequence in all three genes. The absence of SpeB activity in isolates carrying non-null alleles 
in the three genes could be due to alterations in the speB gene, its promoter, or in other mechanisms 
involved in the post-transcriptional or post-translational regulation of SpeB14.
There was no significant association between the SpeB activity of the isolates and infection type. The 
overall distribution of emm types differed significantly between SpeB-producing isolates and those with-
out protease activity (P = 0.0030), but after FDR correction, only emm types 89 and 6 were significantly 
associated with the absence of SpeB (P = 0.0354 for both).
NADase activity. In this work, the NADase activity of the isolates was measured by an endpoint titre 
method based on the degradation of β -NAD by culture supernatants, which results in a reduction of the 
fluorescence emitted by the reduced form of β -NAD. GAS emm1 strains SF370 and MGAS5005 were 
used as controls of the assay. As expected, SF370 presented a low NADase activity (NADase ≤ 3), while 
MGAS5005 was found to have the highest NADase activity level measured (NADase = 192) (Fig. 3). The 
high NADase activity of the latter strain can be attributed to the null covS allele, as well as to a different 
NADase locus from the one carried by old emm1 strains such as SF37029.
The gene encoding the GAS NADase, known as spn or nga, presents multiple variants and has been 
shown to be diverging into NADase-active and -inactive subtypes, which are correlated with emm pat-
terns and tissue tropism30. Therefore, variations in the levels of NADase activity exhibited by distinct 
GAS lineages, which may encode different nga alleles, are expected and were observed among the iso-
lates analysed in this study (Fig.  3 and Supplementary Table S1). Despite this lineage-specific varia-
tion, it was possible to identify a significant association between the highest activity values, namely 
NADase = 96 and NADase = 192, and the presence of null alleles in covS (P = 0.0005), while covR and 
ropB changes did not significantly contribute to an increased NADase activity. In agreement, all the 
strains carrying covS null alleles expressed higher levels of NADase activity than the majority of the 
isolates of the same emm type, except for two emm64 isolates (Fig. 3). The absence of NADase activity 
could be an intrinsic characteristic of this lineage, regardless of the CovRS alleles, due to alterations in 
the nga gene, its promoter, or other regulatory pathways. It is also possible that nga is not part of the 
CovRS regulon in the emm64 clone. Both inter- and intra-serotype differences in the regulatory activity 
of CovRS have been proposed9.
Despite the association between high levels of NADase activity and covS null mutations, it was 
not possible to detect any significant association between the level of NADase activity and invasive 
disease.
Streptolysin S activity. The SLS activity of the isolates was evaluated by an endpoint titre method 
based on the amount of released haemoglobin from sheep erythrocytes during incubation with cul-
ture supernatants. Although the majority of the isolates (n = 179, 94%) presented an SLS activity ≤ 3, it 
was possible to identify multiple isolates with increased SLS activity and that also carried alterations in 
CovRS (Fig. 3). Accordingly, the SLS activity determined for the reference strains SF370 (SLS ≤ 3) and 
MGAS5005 (SLS = 12) were consistent with a de-repression of the sag operon in the latter due to the 
null allele in covS, and a significant association between activity values of SLS = 12 and SLS = 48 and 
covS null alleles was observed (P = 0.0003 and 0.0040, respectively). In fact, all isolates with an SLS ≥ 12 
presented null alleles in covS (Fig. 3 and Supplementary Table S1). Four isolates carrying null alleles and 
belonging to emm types 6, 44, and 64 did not exhibit an increased SLS activity. The coherent low NADase 
and SLS activity among emm64 isolates independent of the CovRS alleles is consistent with a potentially 
different CovRS regulon in these isolates. Among emm6 and emm44 isolates, it is possible that the sag 
operon, which encodes SLS activity, is not regulated by CovRS. Alternatively, SLS activity may not be 
significantly increased in these isolates due to mutations in the sag operon, which have been infrequently 
reported among S. pyogenes isolates31.
It was not possible to detect any significant associations of SLS activity levels with the presence or 
absence of changes in covR and ropB, nor with infection type.
Discussion
Variations at the level of the regulatory networks governing GAS gene expression may constitute key 
elements differentiating strains with a high invasive ability from those that carry the same virulence 
genes, but cause mild infections or asymptomatically colonise the host. Mutations impairing the function 
of the two-component system CovRS and the stand-alone regulator RopB could play this role and have 
been shown to be important in animal models of infection, mostly using representatives of the M1T1 
clone2,3,11,17. However, the actual impact of these mechanisms in invasive human GAS infections remains 
unclear.
In the characterised collection, all three genes (covR, covS, and ropB) presented a high genetic diver-
sity and the allele distribution was closely associated with emm type and ST. Some studies, mostly based 
on murine infection models, suggest that isolates of the highly invasive M1T1 clone have a higher ability 
to acquire covRS mutations than strains of other emm types17,32. However, in our study mutations in the 
covR, covS, and ropB genes were not more prevalent in emm1 or any other emm type. We conclude that 
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among the GAS population causing human infections, the acquisition of mutations in any of the three 
genes can occur in isolates of diverse lineages, in agreement with data from Japan and Taiwan11,12. We 
also did not find a higher prevalence of covRS mutations in isolates carrying the DNase gene sda1 (data 
not shown), although it has been suggested that the presence of the phage encoding this gene exerts a 
selective pressure that favours the acquisition of covRS mutations, at least in the M1T1 genetic back-
ground33.
Null covS alleles were found to have a significant association with invasive infections, while the 
missense alleles in covS and all null and missense alleles in covR and ropB were not differently 
distributed among isolates from pharyngitis and from invasive disease. According to these results, 
only the null alleles in covS would contribute to the transition to invasive infection. In addition, the 
fact that null alleles are significantly more common in covS than in covR supports the hypothesis 
that during the infection process, the acquisition of mutations that impair signalling through CovS, 
while keeping CovR functional and possibly responsive to phosphorylation by other kinases, such 
as SP-STK, may favour the progression to invasive infection19,34. However, this mechanism of transi-
tion to an invasive phenotype seems to be uncommon, since it was found in a minority of invasive 
isolates (10%).
The absence of expansion of isolates carrying null alleles in any of the three analysed genes and the 
fact that they are all under stabilising selection suggests that although mutations compromising the 
activity of these regulators may favour the progression to invasive disease, they are not beneficial to the 
overall fitness of S. pyogenes. Strains carrying covRS null alleles presented decreased ability to survive in 
human saliva and to persist in the murine nasopharynx, leading to the proposal that these strains would 
have an impaired colonisation and transmission capacity19,35. In a murine skin and soft tissue infection 
model, infection with a mixed population containing both the wild-type strain and a derivative covRS 
mutant resulted in higher virulence than infection with either strain alone, highlighting the importance 
of the presence of isolates carrying a functional CovRS2. Therefore, in spite of promoting a switch to a 
phenotype that favours the survival of GAS in deeper tissues, the loss of CovS may affect the success of 
the initial stages of infection8.
In order to evaluate the phenotypic impact of mutations in the covRS and ropB genes, we determined 
the activity of three extracellular proteins that are known to be involved in GAS pathogenesis and to be 
under the direct or indirect influence of these regulators, namely SpeB, NADase, and SLS. A functional 
RopB is considered an absolute requirement for speB transcription13, while the influence of covS muta-
tions in speB expression is more controversial2,5,7,8,17–19,32. Our results support a role of both CovRS and 
RopB in the expression of SpeB, since null alleles in both covS and ropB were associated with the absence 
of SpeB production. Overall, the absence of SpeB activity was significantly more common among emm 
types 6 and 89, both frequently reported among invasive infections, especially emm89, which is one of 
the leading emm types among invasive isolates in several European countries23. However, the emm types 
that have been found to be significantly overrepresented among invasive infections in Portugal, namely 
emm1 and emm6421, were not associated with an increased proportion of SpeB-negative isolates. In 
agreement, the absence of SpeB activity was not associated with invasive infection, indicating that, in 
spite of preserving several virulence factors that are regarded as important for the invasive process, the 
abrogation of SpeB activity cannot explain by itself the higher ability of certain clones to cause invasive 
disease.
Several studies report a significant influence of RopB on the expression of virulence factors other 
than SpeB, including NADase and SLS, either directly or due to the regulation of SpeB or the interaction 
with other transcriptional regulators10,11,24. However, it has been demonstrated that the RopB regulon is 
highly variable, even among strains of the same emm type and that the core regulon is limited to the 
speB and spi genes36. Our results are in agreement with this observation, since changes in ropB were not 
significantly associated with altered NADase or SLS activities. This suggests that, despite the influence 
that the regulator may have in the expression of these proteins in particular lineages, in the overall GAS 
population and under the growth conditions used in this study, RopB does not contribute significantly to 
the expression of the nga and sag operons. In contrast, covS null alleles were significantly associated with 
an increased activity of both NADase and SLS, which is consistent with a repression of the corresponding 
operons by phosphorylated CovR, as demonstrated for the sag promoter18. However, exceptions were 
noted in isolates of specific emm types, including emm64, supporting the existence of differences in the 
CovRS regulon of distinct GAS lineages9. Although both NADase and SLS have been shown to contrib-
ute to GAS cytotoxicity and virulence37,38, their individual activities were not correlated with the type of 
infection caused by the isolates.
The association of missense alleles with invasiveness and with the activities of the studied virulence 
factors is harder to evaluate. Most of the alleles corresponding to amino acid changes in CovS and RopB 
occurred in multiple (often all) isolates of the same emm type, indicating that these are clonal mutations 
and probably do not represent the mechanism described for GAS in which mutations leading to a hyper-
virulent phenotype are acquired during infection2,3. Missense changes can have distinct effects on protein 
function depending on the nature of the amino acid replacement and the region where they occur. It is 
not possible to know from the current data if an altered phenotype in isolates carrying missense alleles 
is due to amino acid changes in these regulators or to some other characteristic of that specific lineage. 
Possibly reflecting this, the prevalence of missense alleles in ropB, covR, and covS could not be associated 
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with the phenotypes tested. When considering only the non-clonal missense alleles, an association with 
SpeB-negative isolates, but not with invasive disease, was observed in the case of ropB. Non-clonal mis-
sense alleles in covRS were not associated with any particular phenotype regarding the tested virulence 
factors, nor with disease presentation.
Null covS alleles are associated with invasive isolates and present phenotypes consistent with the 
ablation of this regulatory system. However, none of the phenotypes is itself associated with invasive-
ness, indicating that other factors under covRS regulation may be responsible for this higher virulence. 
In agreement, impairment of RopB function, known to result in SpeB downregulation, is not associated 
with invasiveness. The data presented supports the abrogation of CovS function as a mechanism con-
tributing to the pathogenesis of invasive GAS infections, although this is not specifically associated with 
lineages identified as having enhanced invasiveness, but occurred in isolates of diverse emm types and 
STs. This mechanism is uncommon and the acquisition of such changes, despite being beneficial in the 
specific context of invasive disease, may incur an overall fitness cost for GAS, preventing their fixation 
in the population.
Materials and Methods
Bacterial strains and culture conditions. GAS isolates used in this study (104 recovered from phar-
yngeal exudates of patients with pharyngitis and 87 associated with invasive disease, recovered from 
normally sterile sites) are listed in Supplementary Table S1 online. The strains were randomly selected 
among a collection of 480 non-duplicate isolates recovered from human infections between 2000 and 
2005 that have been previously characterised21, so as to include one third of the isolates of each emm type 
present in the collection with n ≥ 3, as well as all isolates of emm types 1 and 64. Strains SF370 (CECT 
5109, obtained from Colección Española de Cultivos Tipo) and MGAS5005 (BAA-947, obtained from 
American Type Culture Collection) were used as controls. Strains were grown at 37 °C in Todd Hewitt 
broth (THB) (BD, Sparks, MD, USA) or in Tryptone Soya Agar (Oxoid, Basingstoke, UK) supplemented 
with 5% defibrinated sheep blood.
Molecular typing. In addition to the molecular characterisation of the isolates that had been previ-
ously performed21, multilocus sequence typing analysis was completed for all isolates.
Gene sequencing and analysis. Genomic DNA of the isolates was extracted using cetyl trimeth-
ylammonium bromide (CTAB)39. All PCR and sequencing primers used in this study are listed in 
Supplementary Table S3. The sequences obtained for each isolate were assembled and compared with 
the corresponding regions of the genome of strain SF370 (GenBank AE004092), considered to be the 
reference wild-type alleles.
Geneious R7 (Biomatters, Auckland, New Zealand) was used to search the GenBank database 
(accessed on April 7th 2014) using BLAST for all previously deposited sequences of covR, covS, and ropB 
of S. pyogenes, and align them with the trimmed sequences of the isolates analysed in this study, using 
the MUSCLE algorithm with default settings.
The subset of non-duplicate alleles without indels was used to calculate the ratio of the number of 
nonsynonymous substitutions per nonsynonymous site to the number of synonymous substitutions per 
synonymous site (Ka/Ks), and the respective Z test for stabilising selection, using MEGA5, with the 
Mega-Kumar method (Kimura 2-paramether). Values of P < 0.05 were considered statistically significant. 
Nucleotide diversity was calculated using DnaSP v.5.10.1.
Determination of protease activity. Azocasein assay. SpeB protease activity in stationary phase GAS 
culture supernatants was determined using an adapted azocaseinolytic assay already modified for the 
96-well plate format40,41. Briefly, 24 h-cultures of each strain were diluted 1:10 in fresh THB and grown for 
18 h, in 96-well plates. Bacteria-free supernatants were obtained by centrifugation at 3220 × g for 10 min, 
and transferred to a new microtitre plate. An equal volume of activation buffer (0.1 M sodium acetate 
[pH 5], 1 mM EDTA, 20 mM dithiothreitol) was added and the plate was incubated for 1 h at 40 °C. After 
activation, 2% azocasein (Sigma-Aldrich, St. Louis, MO, USA) (w/v in activation buffer) was added and 
incubated for 6 h at 40 °C. Samples were then precipitated with 2.5 volumes of 6% trichloroacetic acid 
and centrifuged at 15000 × g for 5 min. The optical density at 450 nm of the resulting supernatants was 
determined. The corresponding proteolytic activities were calculated using a calibration curve performed 
for each plate with known concentrations of proteinase K (Roche Diagnostics). Three independent assays 
were performed for each strain. The presence of proteolytic activity was considered positive when at least 
two of the three assays showed a value ≥0.0025 U.
Casein-plate assay. GAS expression of extracellular cysteine protease was determined by a plate assay 
as previously described16. Briefly, single GAS colonies were stab-inoculated into plates of medium 
containing 0.5-strength Columbia broth (BD), 3% w/v skim milk (BD), and 1% w/v agar (Oxoid). 
Protease-expressing strains produced a translucent zone surrounding the site of inoculation after 24-h 
incubation at 37 °C. Three independent assays were performed for each strain. The presence of proteo-
lytic activity was considered positive when at least two of the three assays presented a translucent zone 
of size similar to the one of strain SF370.
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SpeB Western blot analysis. For Western blot analysis, bacterial cultures were grown to late sta-
tionary phase (18 h) and centrifuged at 3200 × g for 15 min. Sterile-filtered supernatants were separated 
by electrophoresis on a 12% SDS-PAGE gel and transferred to a nitrocellulose membrane (Whatman, 
Dassel, Germany) using a Mini Trans-Blot (Bio-Rad, Hercules, CA, USA). Immunodetection was per-
formed by chemiluminescence using monoclonal anti-SpeB antibody (Toxin Technology, Serasota, FL, 
USA) and goat anti-rabbit IgG conjugated with horseradish peroxidase (Santa Cruz Biotechnology, 
Dallas, TX, USA). Detection was performed with ECL detection reagents (Thermo Scientific, Waltham, 
MA, USA) according to the manufacturer’s instructions.
Determination of NADase activity. The NADase activity of each strain was determined by an 
endpoint titre method based on previously published assays37. Briefly, bacteria-free supernatants of 
stationary-phase cultures of GAS strains were obtained as described for the azocasein assay and serially 
diluted (three-fold for the first dilution and two-fold for the second dilution onwards, up to 1/384) in 
β -NAD (Sigma-Aldrich) dissolved in PBS for a final concentration of 0.67 mM, in black 96-well plates 
(transparent bottom) (Greiner Bio-One, Frickenhausen, Germany). Wells containing sterile THB serially 
diluted in PBS and in β -NAD/PBS were used as controls, for each plate. After incubation for 1 h at 37 °C 
in the dark, an equal volume of NaOH was added, for a final concentration of 2 N, and the plates were 
incubated for 1 h at room temperature, in the dark. Fluorescence was measured with excitation at 340 nm 
and emission detection at 460 nm. For each strain, the NADase activity was expressed as the inverse of 
the highest dilution prior to a greater or equal to two-fold increase in the fluorescence value. This method 
has a limit of detection of 3, and strains for which a two-fold increase was not observed and with values 
similar to the THB + β -NAD control were considered to have a NADase activity of ≤3. A minimum of 
three independent assays were performed for each strain, and the majority rule was used to determine 
the final NADase activity.
Determination of streptolysin (SLS) activity. The streptolysin activity of each strain was 
determined by an endpoint titre method adapted from a previously published assay20. Briefly, 
bacteria-free supernatants of stationary-phase cultures of GAS strains were obtained as described 
for the azocasein assay. The supernatants (or sterile THB for control of spontaneous haemolysis – 
blank) were serially diluted in PBS in microplate wells (three-fold for the first dilution and two-fold 
for the second dilution onwards, up to 1/192), and an equal volume of a 2.5% (v/v) suspension of 
defibrinated sheep erythrocytes was added. Two complete haemolysis controls were included in 
each plate, by incubating the erythrocytes suspension with 1% Triton X-100 (positive controls). 
The blank for these wells consisted only of PBS and the erythrocyte suspension. After incubation 
at 37 °C for 1 h, erythrocytes were pelleted and the absorbance at 570 nm of the supernatants was 
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The streptolysin activity was expressed as the inverse of the highest dilution prior to a ≥ two-fold 
decrease in the percentage of haemolysis. This method has a limit of detection of 3, and strains for 
which a two-fold decrease was not observed were considered to have a streptolysin activity of ≤ 3. A 
minimum of three independent assays were performed for each strain, and the majority rule was used 
to determine the final streptolysin activity. In four strains, two with functional covRS alleles (SF370 
and SH0959A in Supplementary Table S1) and another two, of the same emm types, with null covS 
alleles and increased NADase activity (SH1025A and SH0421A in Supplementary Table S1), streptolysin 
assays were also performed in the presence of 33.3 μ g/ml of trypan blue (Sigma-Aldrich) or of 16.7 μ g/
ml cholesterol (Sigma-Aldrich). In all four strains, the results were not significantly changed by the 
presence of cholesterol, while trypan blue completely inhibited haemolysis, indicating that streptolysin 
O does not contribute to the haemolytic activity determined under these conditions, in agreement with 
previous reports20.
Statistical analysis. The allelic diversity of the covR, covS, and ropB genes in the studied collec-
tion of GAS isolates was evaluated using the Simpson’s index of diversity (SID) and corresponding 
95% confidence intervals (CI95%)42. The overall association between covR, covS, or ropB alleles and 
the emm type and ST was evaluated with the Adjusted Wallace coefficient with corresponding 
CI95%43.
Unless otherwise specified, the statistical significance of pairwise associations was evaluated by calcu-
lating the respective odds ratios (when applicable) and the two-tailed Fisher’s exact test, correcting the 
P values for multiple testing through the FDR linear procedure44.
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